Global Pegfilgrastim Biosimilar Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Chemotherapy Treatment
Transplantation
Segment by Application
Hospital Pharmacies
Mail-Order Pharmacies
Retail Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Novartis
Mylan
Coherus BioSciences
Mundipharma International
Biocon
Intas Pharmaceuticals
Pfizer
Dr Reddy’s Laboratories

Table of Content
1 Pegfilgrastim Biosimilar Market Overview
1.1 Product Overview and Scope of Pegfilgrastim Biosimilar
1.2 Pegfilgrastim Biosimilar Segment by Type
1.2.1 Global Pegfilgrastim Biosimilar Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Chemotherapy Treatment
1.2.3 Transplantation
1.3 Pegfilgrastim Biosimilar Segment by Application
1.3.1 Pegfilgrastim Biosimilar Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Mail-Order Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Pegfilgrastim Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Pegfilgrastim Biosimilar Revenue 2016-2027
1.4.2 Global Pegfilgrastim Biosimilar Sales 2016-2027
1.4.3 Pegfilgrastim Biosimilar Market Size by Region: 2016 Versus 2021 Versus 2027
2 Pegfilgrastim Biosimilar Market Competition by Manufacturers
2.1 Global Pegfilgrastim Biosimilar Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pegfilgrastim Biosimilar Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pegfilgrastim Biosimilar Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pegfilgrastim Biosimilar Manufacturing Sites, Area Served, Product Type
2.5 Pegfilgrastim Biosimilar Market Competitive Situation and Trends
2.5.1 Pegfilgrastim Biosimilar Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pegfilgrastim Biosimilar Players Market Share by Revenue
2.5.3 Global Pegfilgrastim Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pegfilgrastim Biosimilar Retrospective Market Scenario by Region
3.1 Global Pegfilgrastim Biosimilar Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Pegfilgrastim Biosimilar Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Pegfilgrastim Biosimilar Market Facts & Figures by Country
3.3.1 North America Pegfilgrastim Biosimilar Sales by Country
3.3.2 North America Pegfilgrastim Biosimilar Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pegfilgrastim Biosimilar Market Facts & Figures by Country
3.4.1 Europe Pegfilgrastim Biosimilar Sales by Country
3.4.2 Europe Pegfilgrastim Biosimilar Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pegfilgrastim Biosimilar Market Facts & Figures by Region
3.5.1 Asia Pacific Pegfilgrastim Biosimilar Sales by Region
3.5.2 Asia Pacific Pegfilgrastim Biosimilar Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pegfilgrastim Biosimilar Market Facts & Figures by Country
3.6.1 Latin America Pegfilgrastim Biosimilar Sales by Country
3.6.2 Latin America Pegfilgrastim Biosimilar Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pegfilgrastim Biosimilar Market Facts & Figures by Country
3.7.1 Middle East and Africa Pegfilgrastim Biosimilar Sales by Country
3.7.2 Middle East and Africa Pegfilgrastim Biosimilar Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pegfilgrastim Biosimilar Historic Market Analysis by Type
4.1 Global Pegfilgrastim Biosimilar Sales Market Share by Type (2016-2021)
4.2 Global Pegfilgrastim Biosimilar Revenue Market Share by Type (2016-2021)
4.3 Global Pegfilgrastim Biosimilar Price by Type (2016-2021)
5 Global Pegfilgrastim Biosimilar Historic Market Analysis by Application
5.1 Global Pegfilgrastim Biosimilar Sales Market Share by Application (2016-2021)
5.2 Global Pegfilgrastim Biosimilar Revenue Market Share by Application (2016-2021)
5.3 Global Pegfilgrastim Biosimilar Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Mylan Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Coherus BioSciences
6.3.1 Coherus BioSciences Corporation Information
6.3.2 Coherus BioSciences Description and Business Overview
6.3.3 Coherus BioSciences Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Coherus BioSciences Product Portfolio
6.3.5 Coherus BioSciences Recent Developments/Updates
6.4 Mundipharma International
6.4.1 Mundipharma International Corporation Information
6.4.2 Mundipharma International Description and Business Overview
6.4.3 Mundipharma International Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mundipharma International Product Portfolio
6.4.5 Mundipharma International Recent Developments/Updates
6.5 Biocon
6.5.1 Biocon Corporation Information
6.5.2 Biocon Description and Business Overview
6.5.3 Biocon Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Biocon Product Portfolio
6.5.5 Biocon Recent Developments/Updates
6.6 Intas Pharmaceuticals
6.6.1 Intas Pharmaceuticals Corporation Information
6.6.2 Intas Pharmaceuticals Description and Business Overview
6.6.3 Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Intas Pharmaceuticals Product Portfolio
6.6.5 Intas Pharmaceuticals Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Dr Reddy’s Laboratories
6.8.1 Dr Reddy’s Laboratories Corporation Information
6.8.2 Dr Reddy’s Laboratories Description and Business Overview
6.8.3 Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Dr Reddy’s Laboratories Product Portfolio
6.8.5 Dr Reddy’s Laboratories Recent Developments/Updates
7 Pegfilgrastim Biosimilar Manufacturing Cost Analysis
7.1 Pegfilgrastim Biosimilar Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pegfilgrastim Biosimilar
7.4 Pegfilgrastim Biosimilar Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pegfilgrastim Biosimilar Distributors List
8.3 Pegfilgrastim Biosimilar Customers
9 Pegfilgrastim Biosimilar Market Dynamics
9.1 Pegfilgrastim Biosimilar Industry Trends
9.2 Pegfilgrastim Biosimilar Growth Drivers
9.3 Pegfilgrastim Biosimilar Market Challenges
9.4 Pegfilgrastim Biosimilar Market Restraints
10 Global Market Forecast
10.1 Pegfilgrastim Biosimilar Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pegfilgrastim Biosimilar by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pegfilgrastim Biosimilar by Type (2022-2027)
10.2 Pegfilgrastim Biosimilar Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pegfilgrastim Biosimilar by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pegfilgrastim Biosimilar by Application (2022-2027)
10.3 Pegfilgrastim Biosimilar Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pegfilgrastim Biosimilar by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pegfilgrastim Biosimilar by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer